GFC Life Science Co., Ltd. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
(주)지에프씨생명과학
20261117
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026-11-17 | |
| Report reference date: | 2026-11-18 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 강희철 |
| Company Name | (주)지에프씨생명과학 | ||
| Entity type | KOSDAQ-Listed Company | Company code | 388610 |
| Total Shares Issued | 5,325,383 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 강희철 | Chinese characters (English) | 姜熙哲 (Kang Hee Cheol) |
| Date of Birth or Business Registration No., etc. | 670521 | |||
| Address (Head Office) [Town/District Level Only] | 경기도 용인시 수지구 성복1로 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | CEO |
| Appointment Date | 2003-05-16 | Resignation Date | - | |
| Major Shareholder | De facto controlling shareholder | |||
| Business contact and person in charge | Affiliated company | 주식회사 지에프씨생명과학 | Department | 경영관리본부 |
| Position | Manager | Phone Number | 031-51*** | |
| Name | 박윤정 | Fax number | 031-51*** | |
| Email address | **@gfcos.co.kr | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2026-11-16 | 1,770,887 | 33.25 | 1,770,887 | 33.25 |
| This Report | 2026-11-18 | 1,771,680 | 33.27 | 1,771,680 | 33.27 |
| Change | 793 | 0.02 | 793 | 0.02 | |
주1) 2026-11-17~11월 18일(결제일) 최대주주 강희철 대표이사 장내매수 (총793주)
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 1,771,680 | - | - | - | - | - | - | - | 1,771,680 | 33.27 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 5,325,383 | - | 33.27 | 33.27 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| On-Market Purchase (+) | 2026-11-17 | Common Stock | 1,770,887 | 241 | 1,771,128 | 4,121 | - | - |
| On-Market Purchase (+) | 2026-11-18 | Common Stock | 1,771,128 | 552 | 1,771,680 | 3,898 | - | - |
| Total | 1,770,887 | 793 | 1,771,680 | - | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities